These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 38349418)

  • 21. Pathogenesis of primary acquired nasolacrimal duct obstruction.
    Kashkouli MB; Sadeghipour A; Kaghazkanani R; Bayat A; Pakdel F; Aghai GH
    Orbit; 2010 Feb; 29(1):11-5. PubMed ID: 20302403
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Topographic and anatomical features of the nasolacrimal duct obstruction due to radioiodine treatment.
    Yartsev VD; Atkova EL; Ekaterinchev MA
    Int Ophthalmol; 2023 Sep; 43(9):3385-3390. PubMed ID: 37199817
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Conjunctival cytologic features in patients with unilateral primary acquired nasolacrimal duct obstruction.
    Yuksel N; Mutlu M; Kilicarslan A; Akcay E
    Int Ophthalmol; 2018 Feb; 38(1):323-326. PubMed ID: 28224303
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Liquid-based thin-prep cytology study of lacrimal drainage system in primary acquired nasolacrimal duct obstruction.
    Jang JK; Choi SE; Lew H
    Graefes Arch Clin Exp Ophthalmol; 2022 Sep; 260(9):3053-3059. PubMed ID: 35471740
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Micro-Reflux Test: a new test to evaluate nasolacrimal duct obstruction.
    Camara JG; Santiago MD; Rodriguez RE; Medalle RA; Young DA; Atebara NH
    Ophthalmology; 1999 Dec; 106(12):2319-21. PubMed ID: 10599664
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Is gastroesophageal reflux disease associated with primary acquired nasolacrimal duct obstruction?
    Mehta S; Ying GS; Hussain A; Harvey JT
    Orbit; 2018 Apr; 37(2):135-139. PubMed ID: 29040001
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Primary acquired nasolacrimal duct obstruction: is it really related to paranasal abnormalities?
    Yazici H; Bulbul E; Yazici A; Kaymakci M; Tiskaoglu N; Yanik B; Ermis S
    Surg Radiol Anat; 2015 Aug; 37(6):579-84. PubMed ID: 25422096
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Outcomes of Endoscopic Dacryocystorhinostomy in Secondary Acquired Nasolacrimal Duct Obstruction: A Case-Control Study.
    Sweeney AR; Davis GE; Chang SH; Amadi AJ
    Ophthalmic Plast Reconstr Surg; 2018; 34(1):20-25. PubMed ID: 27997463
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quantitative analysis of both lacrimal glands in unilateral primary acquired nasolacrimal duct obstruction, based on three-dimensional fast spin echo-Cube-Flex.
    Zhao Y; Tian M; Luo B; Liang W; Wu H; Wang Q; Zhang J
    Eur J Radiol; 2022 Nov; 156():110517. PubMed ID: 36108476
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anatomic characteristics of primary acquired nasolacrimal duct obstruction: a comparative computed tomography study.
    Wang W; Gong L; Wang Y
    Quant Imaging Med Surg; 2022 Nov; 12(11):5068-5079. PubMed ID: 36330196
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sinonasal Anatomical Variations and Primary Acquired Nasolacrimal Duct Obstruction: A Single Centre, Case-Control Investigation.
    Samarei R; Samarei V; Aidenloo NS; Fateh N
    Eurasian J Med; 2020 Feb; 52(1):21-24. PubMed ID: 32158308
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diameter of the bony lacrimal canal: normal values and values related to nasolacrimal duct obstruction: assessment with CT.
    Janssen AG; Mansour K; Bos JJ; Castelijns JA
    AJNR Am J Neuroradiol; 2001 May; 22(5):845-50. PubMed ID: 11337326
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinicopathologic analysis of 166 patients with primary acquired nasolacrimal duct obstruction.
    Lee-Wing MW; Ashenhurst ME
    Ophthalmology; 2001 Nov; 108(11):2038-40. PubMed ID: 11713075
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prolactin and Prolactin-inducible protein (PIP) in the pathogenesis of primary acquired nasolacrimal duct obstruction (PANDO).
    Ali MJ; Paulsen F
    Med Hypotheses; 2019 Apr; 125():137-138. PubMed ID: 30902142
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Incidence of canalicular closure with endonasal dacryocystorhinostomy without intubation in primary nasolacrimal duct obstruction.
    Cannon PS; Chan W; Selva D
    Ophthalmology; 2013 Aug; 120(8):1688-92. PubMed ID: 23642376
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reliable, Noncontact Imaging Tool for the Evaluation of Meibomian Gland Function: Sirius Meibography.
    Gulmez Sevim D; Gumus K; Unlu M
    Eye Contact Lens; 2020 Mar; 46 Suppl 2():S135-S140. PubMed ID: 31469754
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of primary acquired nasolacrimal duct obstruction: Comparison of CT-DCG and dacryoendoscopy in accurately localizing the lacrimal drainage obstructions.
    Zhang W; Li L; Zhang L; Ding Y; Liu X; Ali MJ; Xiao C
    Eur J Ophthalmol; 2024 Feb; ():11206721241230581. PubMed ID: 38327083
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Predisposing factors for primary acquired nasolacrimal duct obstruction.
    Ohtomo K; Ueta T; Toyama T; Nagahara M
    Graefes Arch Clin Exp Ophthalmol; 2013 Jul; 251(7):1835-9. PubMed ID: 23446557
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reliability of fluorescein dye disappearance test in assessment of adults with nasolacrimal duct obstruction.
    Kashkouli MB; Mirzajani H; Jamshidian-Tehrani M; Pakdel F; Nojomi M; Aghaei GH
    Ophthalmic Plast Reconstr Surg; 2013; 29(3):167-9. PubMed ID: 23503058
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Degree of agreement between dacryoscintigraphy and dacryocystography examinations results in primary acquired nasolacrimal duct obstruction.
    Aditya E; Irawati Y; Zulkarnaien B; Prihartono J
    Nucl Med Rev Cent East Eur; 2022; 25(1):12-17. PubMed ID: 35137932
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.